In vitro studies revealed that EGFR-targeted CAR-T cells exhibit specific cytolytic activity and produce high levels of cytokine (IL-2, IL-4, IL-10, TNF-α, and interferon-γ [IFN-γ]) against EGFR-positive tumor cells (42). The gene discussed is IL10; the disease is neoplasm.